Alerts & notifications

Heroin sold as ketamine in Auckland region

Heroin has been found in a white powder that was sold as ketamine in the Auckland region.

Highly potent synthetic opioid misrepresented as butonitazene

More highly potent nitazene variations have been identified.

Fake oxycodone tablets linked to serious harm

Fake oxycodone tablets, containing metonitazene, may be linked to a recent death and serious hospitalisations in New Zealand

Misrepresented MDMA linked to serious harm in Hawke’s Bay

UPDATED 11 August 2023
Serious harm has been linked with misrepresented MDMA in the Hawke’s Bay area.

Synthetic Cannabinoid misrepresented as DMT

Synthetic Cannabinoid MDMB-4en-PINACA has been detected in a yellow powder presumed to be DMT

Potent stimulant Alpha-PVP misrepresented as MDMA

An off-white powder being sold as MDMA in Auckland has been found to contain Alpha-PVP.

Synthetic cannabinoid harm in Christchurch linked to hospitalisations

A particularly dangerous batch of synthetic cannabinoids has been linked to serious harm in Christchurch in November 2022.

Yellow tablet/powder containing potent opioid likely to cause serious harm

UPDATED 28 MARCH 2023
Serious harm has been identified in relation to metonitazene found in a yellow powder. High Alert urges continued caution, particularly in the Auckland region.

Fentanyl in white powder causes multiple hospitalisations in Wairarapa region

UPDATED 1 JULY 2022
Fentanyl found in white powder linked to serious harm events in the Wairarapa region.

Misrepresented MDMA linked to serious harm in Whanganui area

An unknown brown powder being sold as MDMA has been linked to serious harm events in the Whanganui area.